Moreover, several groups reported Il-17 as an important cytokine in the early phase of RA development, acting through the stimulation of other pro-inflammatory mediators and the induction of matrix metalloproteinases (MMPs) (5). Here, IL17A is linked to rheumatoid arthritis.